Licensing Biotech Intellectual Property in University-Industry Partnerships

被引:14
作者
Drozdoff, Vladimir [1 ]
Fairbairn, Daryl [2 ]
机构
[1] Cold Spring Harbor Lab, Business Dev & Technol Transfer, Cold Spring Harbor, NY 11721 USA
[2] Clifford Chance US LLP, New York, NY 10019 USA
关键词
D O I
10.1101/cshperspect.a021014
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Appropriate negotiation and drafting of license agreements are critical to successfully establishing and managing the expansive and complex relationships that are becoming more common between industry and universities. More often than not, the resulting licensing agreements become quite lengthy and complex, and the key principles become difficult to discern among all the details. This summary provides a short, nonexhaustive introduction to some of the essential components of these licenses with the intent of providing the non-licensing professional a better appreciation of some of the key commercial and legal terms from both an academic and company perspective, keeping in mind some of the considerations that particularly apply to biotechnology deals.
引用
收藏
页数:12
相关论文
共 10 条
[1]  
AUTM, 2007, PUBL INT 9 POINTS CO
[2]  
AUTM, 2012, US LIC ACT SURV FY 2
[3]   Bayh-Dole: if we knew then what we know now [J].
Boettiger, S ;
Bennett, AB .
NATURE BIOTECHNOLOGY, 2006, 24 (03) :320-323
[4]  
Brody H, 2001, MIT TECHNOLOGY REV
[5]  
Cressey D, 2012, NATURE NEWS BLO 1012
[6]   Value creation and sharing among universities, biotechnology and pharma [J].
Edwards, MG ;
Murray, F ;
Yu, R .
NATURE BIOTECHNOLOGY, 2003, 21 (06) :618-624
[7]  
FELDMAN MP, 2007, HDB BEST PRACTICES
[8]   Accountability in patenting of federally funded research [J].
Rai, Arti K. ;
Sampat, Bhaven N. .
NATURE BIOTECHNOLOGY, 2012, 30 (10) :953-957
[9]   Partnering with the professor [J].
Schachter, Beth .
NATURE BIOTECHNOLOGY, 2012, 30 (10) :944-952
[10]  
United States (US) National Institutes of Health (NIH), 1999, FED REG, V64, P72090